TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 29 filers reported holding TENAX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $53,368 | -34.1% | 479,065 | 0.0% | 0.00% | – |
Q3 2022 | $81,000 | -43.8% | 479,065 | 0.0% | 0.00% | – |
Q2 2022 | $144,000 | -65.1% | 479,065 | -6.2% | 0.00% | – |
Q1 2022 | $413,000 | -22.5% | 510,718 | -0.3% | 0.00% | – |
Q4 2021 | $533,000 | -41.2% | 512,284 | +0.2% | 0.00% | – |
Q3 2021 | $906,000 | -14.9% | 511,414 | -0.1% | 0.00% | – |
Q2 2021 | $1,065,000 | -6.4% | 512,110 | -14.5% | 0.00% | – |
Q1 2021 | $1,138,000 | +2.2% | 599,102 | 0.0% | 0.00% | – |
Q4 2020 | $1,114,000 | +20.7% | 599,102 | 0.0% | 0.00% | – |
Q3 2020 | $923,000 | +70.0% | 599,102 | 0.0% | 0.00% | – |
Q2 2020 | $543,000 | +58.8% | 599,102 | 0.0% | 0.00% | – |
Q1 2020 | $342,000 | -59.5% | 599,102 | 0.0% | 0.00% | – |
Q4 2019 | $845,000 | +17.5% | 599,102 | 0.0% | 0.00% | – |
Q3 2019 | $719,000 | -13.1% | 599,102 | 0.0% | 0.00% | – |
Q2 2019 | $827,000 | -31.7% | 599,102 | 0.0% | 0.00% | – |
Q1 2019 | $1,210,000 | +120900.0% | 599,102 | +95450.6% | 0.00% | – |
Q4 2018 | $1,000 | -66.7% | 627 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | -25.0% | 627 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | +33.3% | 627 | +0.3% | 0.00% | – |
Q1 2018 | $3,000 | – | 625 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 43,164 | $61,000 | 0.02% |
FAS Wealth Partners, Inc. | 58,576 | $83,000 | 0.01% |
Gradient Investments LLC | 1 | $0 | 0.00% |
Hudock, Inc. | 1 | $0 | 0.00% |
Allworth Financial LP | 1 | $0 | 0.00% |
VANGUARD GROUP INC | 12,200 | $17,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,018 | $7,000 | 0.00% |
UBS Group AG | 72 | $0 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
Advisor Group, Inc. | 3,065 | $4,000 | 0.00% |